Matthew Siegel is vice president of medical affairs at Maine Behavioral Healthcare in Portland.
Matthew Siegel
Vice president
Maine Behavioral Healthcare
From this contributor
Autism can mask anxiety symptoms
Anxiety is one of the most common mental health conditions, as well as one of the most treatable. But when a person has autism, anxiety symptoms can be hard to see. Matthew Siegel calls for anxiety tests and treatments that are tailored to people with autism.
Searching for psychiatrists with expertise in autism
There is an urgent need for psychiatrists who are trained to care for individuals with autism. Matthew Siegel calls for a formal training program in autism for psychiatrists.
Searching for psychiatrists with expertise in autism
Explore more from The Transmitter
‘Push-pull’ recipe for neural wiring used in multiple brain regions
A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.
‘Push-pull’ recipe for neural wiring used in multiple brain regions
A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.
Reward-learning algorithm hardwired into dopamine circuit
The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.
Reward-learning algorithm hardwired into dopamine circuit
The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.